Frontlight ResearchEarly access
Trial site
Azienda Ospedaliera-Universitaria Di Cosenza
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers5 trials
- Acute lymphoblastic leukaemia3 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Multiple myeloma2 trials
- Obesity2 trials
- Acute myeloid leukaemia1 trial
- Chronic kidney disease1 trial
- Heart failure1 trial
- High blood pressure1 trial
- IgA nephropathy1 trial
- Sarcoma1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Recruiting7 trials
- Active, not recruiting3 trials
- Completed3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Anthos Therapeutics, Inc.2 trials
- Novo Nordisk A/S2 trials
- Associazione Italiana Ematologia Oncologia Pediatrica1 trial
- AstraZeneca1 trial
- Boehringer Ingelheim1 trial
- and 7 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Recruiting
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Obesity2 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Sarcoma1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026